Filip Banovac, M.D.

Associate Professor
Faculty Appointments
Associate Professor of Radiology and Radiological Sciences
M.D., Medicine, Medical College of Virginia, Richmond, VirginiaB.S., Biomedical Engineering, Duke University, Durham, North Carolina
Clinical Description
Filip Banovac, M.D., is a graduate of Duke University and attended medical school at Medical College of Virginia in Richmond. After a residency at Georgetown, he completed the National Institutes of Health (NIH) Postdoctoral Fellowship at the National Heart Lung and Blood Institute and fellowship training in Vascular and Interventional Radiology at Stanford. He joined the faculty at Vanderbilt University Medical Center in 2015 as the section chief of Interventional Radiology. His research interests include augmented instrument navigation and precision delivery of instruments into imaging targets. He was a collaborator at the NIH Center for Interventional Oncology. In 2009 he was awarded the Gary Becker Young Investigator Award by the Society of Interventional Radiology (SIR), where he has served as the Research Policy division chair, vice chair and currently chair of the SIR Foundation.

Section: Interventional
Watchmaker JM, Lipnik AJ, Fritsche MR, Baker JC, Mouli SK, Geevarghese S, Banovac F, Omary RA, Brown DB. Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy?. J Surg Oncol [print-electronic]. 2018 May; 117(6): 1312-7. PMID: 29513895, DOI: 10.1002/jso.24993, ISSN: 1096-9098.

Fritsche MR, Watchmaker JM, Lipnik AJ, Baker JC, Geevarghese S, Banovac F, Omary RA, Brown DB. Outpatient Transarterial Chemoembolization of Hepatocellular Carcinoma: Review of a Same-Day Discharge Strategy. J Vasc Interv Radiol [print-electronic]. 2018 Feb 2/23/2018; PMID: 29478795, PII: S1051-0443(17)31038-2, DOI: 10.1016/j.jvir.2017.11.018, ISSN: 1535-7732.

Taussig MD, Irene Koran ME, Mouli SK, Ahmad A, Geevarghese S, Baker JC, Lipnik AJ, Banovac F, Brown DB. Neutrophil to lymphocyte ratio predicts disease progression following intra-arterial therapy of hepatocellular carcinoma. HPB (Oxford) [print-electronic]. 2017 Feb 2/9/2017; PMID: 28190710, PII: S1365-182X(17)30043-6, DOI: 10.1016/j.hpb.2017.01.013, ISSN: 1477-2574.

Koran ME, Stewart S, Baker JC, Lipnik AJ, Banovac F, Omary RA, Brown DB. Five percent dextrose maximizes dose delivery of Yttrium-90 resin microspheres and reduces rates of premature stasis compared to sterile water. Biomed Rep [print-electronic]. 2016 Dec; 5(6): 745-8. PMID: 28105342, PMCID: PMC5228356, PII: BR-0-0-799, DOI: 10.3892/br.2016.799, ISSN: 2049-9434.

Koran ME, Lipnik AJ, Baker JC, Banovac F, Omary RA, Brown DB. Procedural Impact of a Dedicated Interventional Oncology Service Line in a National Cancer Institute Comprehensive Cancer Center. J Am Coll Radiol [print-electronic]. 2016 Jun 6/11/2016; PMID: 27297700, PII: S1546-1440(16)30307-6, DOI: 10.1016/j.jacr.2016.04.033, ISSN: 1558-349X.